coronavirus
larg
envelop
positivestrand
rna
virus
broad
host
rang
capabl
infect
mani
speci
particularli
tissu
upper
respiratori
gastrointestin
tract
liver
cn
coronavirus
human
coronaviru
hcov
major
caus
agent
common
cold
human
year
cold
usual
mild
self
limit
clear
increas
neutralis
antibodi
titr
soon
infect
howev
certain
percentag
popul
reinfect
viru
cold
due
coronaviru
infect
particularli
preval
winter
fact
outbreak
two
known
human
coronavirus
occur
altern
year
becom
common
season
event
coronaviru
infect
previous
consid
seriou
enough
requir
treatment
either
vaccin
specif
antivir
therapi
situat
may
alter
sinc
quasipandem
outbreak
late
earli
sever
acut
respiratori
syndrom
sar
caus
newli
identifi
coronaviru
sarscov
diseas
typic
influenzalik
symptom
high
fever
myalgia
dyspnea
lymphopenia
lung
infiltr
pneumonia
develop
acut
breath
problem
rais
overal
mortal
result
total
probabl
sar
case
report
novemb
juli
die
shown
sarscovposit
owe
abrupt
pandem
outbreak
certain
empir
measur
antibiot
antivir
agent
ribavirin
oseltamivir
proteas
inhibitor
corticosteroid
ifn
normal
human
immunoglobulin
prepar
appli
treat
suffer
sar
research
continu
test
kind
regimen
treat
sar
includ
neutralis
antibodi
fusion
inhibitor
natur
product
vaccin
rna
interfer
rnai
largescal
reemerg
rule
even
though
sporad
sar
infect
report
sinc
june
result
antivir
drug
high
activ
sarscov
high
demand
rnai
innat
adapt
defenc
mechan
trigger
doublestrand
rna
dsrna
recent
small
interf
rna
sirna
shown
promis
protect
viral
invas
inhibit
express
viral
antigen
accessori
gene
well
control
transcript
replic
viral
genom
review
focus
current
inform
avail
viral
gene
express
coronaviru
genom
replic
base
knowledg
rnai
strategi
design
interfer
viral
replic
treatment
sarscov
infect
review
coronavirus
genu
coronavirida
famili
larg
envelop
positivestrand
rna
virus
caus
agent
mani
infecti
diseas
human
anim
viral
envelop
stud
long
petalshap
spike
give
viru
characterist
crown
appear
name
sar
outbreak
coronavirus
antigen
divid
three
group
virus
within
group
classifi
basi
host
nucleotid
sequenc
serolog
relationship
member
group
includ
porcin
transmiss
gastroenter
viru
tgev
porcin
respiratori
coronaviru
prcv
felin
infecti
periton
viru
fipv
felin
enter
viru
fecov
canin
coronaviru
ccov
wherea
mous
hepat
viru
mhv
bovin
coronaviru
bcov
belong
group
ii
group
iii
includ
avian
infecti
bronchiti
viru
ibv
turkey
coronaviru
tcov
gene
analysi
entir
sarscov
rna
genom
nucleotid
suggest
sarscov
includ
coronavirida
famili
although
sarscov
react
antibodi
group
virus
sarscov
clearli
repres
new
group
coronaviru
virion
coronaviru
spheric
particl
nm
diamet
contain
cap
polyadenyl
singlestrand
positivesens
genom
rna
kb
length
largest
known
rna
viru
genom
coronavirusinfect
cell
contain
characterist
cotermin
nest
mrna
mrna
cap
leader
sequenc
consist
nucleotid
deriv
end
genom
untransl
region
utr
nucleotid
follow
leader
sequenc
anoth
utr
end
rna
genom
follow
polya
tail
variabl
length
import
rna
replic
transcript
transcriptionregulatori
sequenc
tr
typic
featur
coronavirus
short
motif
usual
near
begin
open
read
frame
orf
end
leader
sequenc
figur
addit
consensu
sequenc
found
immedi
front
spike
protein
membran
protein
gene
orf
gene
organis
coronavirus
follow
pattern
gene
code
polyprotein
b
envelop
protein
e
nucleocapsid
protein
n
figur
group
ii
coronavirus
fring
short
spike
consist
haemagglutinin
esteras
coronaviru
genom
also
contain
varieti
addit
orf
encod
nonstructur
protein
known
function
gene
conserv
among
coronavirus
polyprotein
b
requir
viral
rna
synthesi
believ
viral
protein
synthesis
directli
origin
viral
viral
protein
translat
subgenom
mrna
viral
rna
synthesi
take
place
product
gene
translat
newli
synthesis
genom
rna
primari
gene
product
orf
b
predict
kda
undergo
co
posttransl
process
variou
protein
result
proteas
activ
virusencod
proteas
papainlik
cystein
proteas
plpro
cystein
proteas
cleav
polypeptid
small
polypeptid
requir
replic
transcript
rnadepend
rna
polymeras
rdrp
helicas
essenti
compon
replicas
complex
presum
contain
viral
cellular
protein
replicas
complex
respons
transcrib
fulllength
neg
posit
rna
cotermin
set
nest
subgenom
mrna
subgenom
neg
rna
strand
entri
envelop
coronavirus
usual
involv
three
step
attach
receptor
bind
viruscel
fusion
mediat
viral
envelop
protein
glycoprotein
make
larg
petalshap
spike
surfac
virion
bind
cellular
receptor
promot
fusion
viral
cellular
membran
event
probabl
explain
primari
viral
tropism
highli
glycosyl
protein
molecular
mass
kda
divid
three
structur
domain
larg
extern
ntermin
domain
divid
subdomain
transmembran
domain
short
ctermin
cytoplasm
domain
mani
case
cell
receptor
coronavirus
identifi
mhv
receptor
murin
biliari
glycoprotein
belong
carcinoembryon
antigen
famili
ig
superfamili
cell
membranebound
metalloproteinas
aminopeptidas
n
probabl
receptor
tgev
ccov
wide
distribut
cell
mani
tissu
includ
respiratori
enter
epitheli
neuron
glial
cell
receptor
sarscov
consid
angiotensinconvert
enzym
requir
bind
permiss
cell
subunit
receptor
type
iii
virus
yet
identifi
integr
membran
protein
e
minimum
protein
unit
requir
viru
assembl
protein
found
viral
envelop
also
viral
intern
core
associ
golgi
complex
cell
therebi
dictat
site
viru
assembl
express
e
protein
may
suffici
enough
trigger
format
viruslik
particl
vlp
protein
coexpress
e
protein
incorpor
vlp
presum
authent
conform
abl
infect
cell
contain
viral
nucleic
acid
vlp
ideal
candid
vaccin
prepar
final
structur
protein
n
protein
molecular
mass
kda
probabl
associ
viral
rna
form
long
flexibl
helic
nucleocapsid
n
protein
may
also
play
role
viral
rna
synthesi
coronaviru
rna
polymeras
activ
inhibit
vitro
antin
protein
antibodi
dsrna
usual
play
pivot
role
intrins
intermedi
genom
replic
mani
virus
rare
eukaryot
cell
higher
eukaryot
respond
dsrna
regardless
whether
produc
virus
introduc
artifici
form
immun
defenc
respons
mammalian
cell
expos
dsrna
major
immun
respons
increas
serum
ifn
level
suppress
viral
spread
inhibit
viral
gene
express
initi
apoptosi
infect
cell
contrast
mammalian
cell
mani
higher
eukaryot
includ
plant
nematod
insect
abl
mount
ifn
respons
nonetheless
rnai
first
describ
plant
act
natur
immun
mechan
viral
infect
trigger
posttranscript
gene
silenc
ptg
sirna
molecul
observ
wide
varieti
speci
rnai
power
techniqu
wide
use
silenc
specif
gene
mammalian
human
cell
howev
dsrna
bp
destroy
induc
immun
respons
mammalian
cell
activ
dsrnadepend
kinas
synthetas
lead
induct
ifn
express
rel
small
size
synthet
sirna
escap
immun
respons
result
research
develop
mani
rnaibas
drug
prevent
treat
diseas
viral
infect
tumour
metabol
disord
recent
studi
indic
rnai
exert
effect
via
twostep
mechan
initi
effector
step
initi
step
long
dsrna
introduc
either
directli
via
transgen
viru
subsequ
host
protein
dicer
atpdepend
ribonucleas
member
rnase
iii
famili
bind
high
affin
introduc
dsrna
cleav
nucleotid
fragment
refer
sirna
duplex
effector
step
sirna
duplex
complex
multinucleas
form
socal
rnainduc
silenc
complex
risc
undergo
atpdepend
activ
step
result
unwind
doublestrand
sirna
compon
form
singlestrand
guid
rna
lead
risc
complementari
mrna
mrna
bound
unidentifi
ribonucleas
compon
risc
cleav
bound
mrna
centr
region
complementari
guid
rna
reaction
taken
place
risc
releas
seek
mrna
homologu
time
cleav
mrna
degrad
cellular
exonucleas
effect
rnai
improv
use
rnadirect
rna
polymeras
produc
larg
number
copi
trigger
rna
specif
target
sirna
import
slight
posit
chang
sirna
rel
mrna
drastic
effect
silenc
indic
secondari
structur
target
mrna
play
role
sirna
access
howev
exact
sequenc
match
sens
strand
sirna
duplex
may
necessari
singlestrand
antisens
sirna
shown
initi
cleavag
target
rna
mani
five
mismatch
sensestrand
rna
toler
contrast
singl
basepair
mismatch
antisens
strand
correspond
target
rna
significantli
reduc
sirnamedi
messag
degrad
genet
mutat
region
code
major
antigen
protein
may
limit
inhibitori
effect
sirna
circumv
sequenc
variat
among
viral
strain
highli
conserv
sirna
target
sequenc
must
select
possibl
target
sequenc
chosen
beyond
code
region
may
structur
role
gener
guidelin
choic
sirna
sequenc
report
g
c
bp
end
sens
strand
bp
atrich
sequenc
end
antisens
strand
gc
stretch
bp
highli
recommend
sirna
prepar
enzymat
advantag
improv
effici
lower
cost
addit
provid
larg
panel
sirna
cover
long
segment
mrna
avoid
reemerg
escap
mutant
anoth
method
use
rna
polymeras
transcrib
sirna
short
dna
templat
encod
sirna
downstream
rna
promot
major
limit
use
either
chemic
enzymat
synthesis
sirna
unstabl
may
transient
effect
howev
use
chemic
protect
sirna
viral
vector
may
avoid
problem
rnai
technolog
ideal
tool
inhibit
viral
replic
host
cell
sirna
interact
certain
viral
gene
silenc
express
also
use
probe
step
viral
cycl
plusstrand
rna
virus
figur
also
mani
type
viru
gene
encod
vital
protein
reproduc
sarscov
virion
chosen
chemotherapeut
intervent
eg
code
proteas
rnadepend
rna
polymeras
possibl
gene
product
involv
viralproteinmedi
process
first
demonstr
sirna
abl
silenc
replicas
sarscov
region
genom
approach
effect
vitro
sarscov
wang
et
al
subsequ
observ
vectorbas
sirna
could
inhibit
replic
sarscov
show
express
plasmid
psuper
sirna
specif
target
viral
rna
polymeras
could
block
cytopath
effect
sarscov
vero
cell
plasmid
also
abl
block
viral
replic
shown
titr
level
viral
rna
protein
zhang
et
al
report
sirna
reduc
cytopath
effect
use
transfect
cell
immedi
sarscov
infect
moreov
zhang
et
al
show
dna
vectordriven
sirna
select
silenc
gene
express
sarsinfect
cell
report
sirna
target
leader
sequenc
decreas
mrna
level
protein
level
report
gene
cell
addit
steadi
express
sirna
cell
decreas
transcript
sarscov
gene
mrna
furthermor
research
point
sirna
specif
leader
sequenc
stronger
inhibitori
effect
sarscov
replic
target
either
gene
antisens
oligodeoxynucleotid
zheng
et
al
show
three
chemic
synthesis
sirna
duplex
target
viral
rna
polymeras
one
target
gene
potent
inhibit
sarscov
infect
replic
fetal
rhesu
kidney
cell
observ
prolong
prophylact
effect
sirna
duplex
inhibit
transcript
last
h
combin
activ
sirna
duplex
target
differ
region
viral
genom
result
inhibit
author
focus
four
region
sarscov
genom
leader
sequenc
tr
proteincod
sequenc
purposedesign
sirna
prepar
test
specif
sarscov
viral
rna
examin
inhibitori
effect
viral
protein
express
replic
result
show
genetarget
sirna
profoundli
reduc
level
rna
transcript
viral
antigen
although
sirna
effect
two
sirna
effect
sirna
result
mention
obtain
cell
cultur
studi
recent
studi
use
mous
model
demonstr
airway
infect
caus
influenza
viru
respiratori
syncyti
viru
treat
prophylact
intranas
deliveri
sirna
li
et
al
administ
chemic
synthesis
sirna
duplex
intranas
rhesu
macaqu
sar
model
found
reduct
sarscov
infectioninduc
fever
sarscov
viral
level
acut
diffus
alveoli
damag
accumul
dosag
sirna
mgkg
result
sirnainduc
toxic
result
provid
strong
evid
sirna
agent
potent
prophylact
therapeut
treatment
sar
infect
well
lack
toxic
nonhuman
primat
model
encourag
find
suggest
sirna
may
applic
sarscov
man
suppress
viral
cycl
express
viral
antigen
use
rnai
treatment
show
promis
therapi
viral
infect
convent
drug
vaccin
use
treatment
viral
diseas
may
mani
advers
effect
toxic
cost
resist
complic
administr
protocol
consider
inform
regard
mechan
use
rnai
tool
manipul
gene
express
inhibit
viral
replic
obtain
recent
year
mark
advantag
sirna
attribut
rel
eas
design
construct
test
particular
low
cost
importantli
sirna
short
length
nucleic
acid
believ
gener
unfavour
immun
respons
administ
patient
thu
make
ideal
candid
treatment
viral
infect
sirna
normal
carri
neg
charg
physiolog
condit
make
difficult
molecul
travers
cell
membran
carrier
liposom
mani
viral
vector
electropor
effici
deliv
sirna
mammalian
cell
current
challeng
success
sirnabas
treatment
precis
deliv
sirna
effici
safe
way
target
cell
organ
consider
effort
requir
better
understand
virolog
develop
techniqu
sirnabas
drug
may
soon
deploy
reliev
even
erad
intract
viral
infect
current
afflict
mankind
work
fund
nation
scienc
council
taiwan
author
greatli
indebt
ys
chang
changgung
univers
tl
li
nation
taiwan
ocean
univers
mani
invalu
suggest
barka
critic
evalu
english
